CQuentia’s proprietary Perioperative Pharmacogenomic testing program utilizes the patient’s unique individual genetic profile to identify how he or she will respond to various medications used during and after surgery. Our report also identifies a patient’s genetic risk for malignant hyperthermia, thrombosis, or a pseudocholinesterase deficiency. CQuentia’s proprietary process includes a genetic testing panel, developed incorporating the guidelines defined by the Clinical Pharmacogenetics Implementation Consortium (CPIC), and an anesthesia report created by anesthesiologists, for anesthesiologists.
The combined view of medication efficacy and risk factors provides a greater level of patient detail that directly impacts the success of the surgical event. CQuentia’s PGx-guided medication management has proven to reduce narcotic use during surgery, decrease instances of post-operative side effects (such as nausea/vomiting) and improve post-operative pain scores.
Find out what Dr. Richard Shapiro, Executive Associate Clinical Director of MedStar Medical Group Anesthesiology, have to say about working with CQuentia.
CQuentia, more than a lab, more than a test. The leaders in the new frontier of genomic testing and personalized medicine.